Company Filing History:
Years Active: 1997-2005
Title: Susan Hockfield: Innovator in Neuroscience
Introduction
Susan Hockfield is a prominent inventor based in North Haven, CT (US). She has made significant contributions to the field of neuroscience, particularly in the study of primary central nervous system (CNS) tumors. Her work has led to the development of innovative treatments that aim to improve the survival rates of mammals affected by these tumors.
Latest Patents
Susan Hockfield holds 2 patents that focus on critical advancements in cancer treatment. One of her latest patents involves the inhibition of BEHAB cleavage and its relation to primary CNS tumors. This invention provides useful compositions and methods for reducing tumor volume and increasing the length of survival in mammals with primary CNS tumors. It also includes methods for identifying compounds that can aid in treating these tumors. Another significant patent pertains to DNA encoding BEHAB, a brain hyaluronan-binding protein. This gene is isolated from brain tissue and is characterized by its high degree of sequence homology to other hyaluronan-binding proteins. Notably, BEHAB is expressed at increased levels in human glioma tissue, making it a valuable marker for diagnostic purposes.
Career Highlights
Susan Hockfield has had a distinguished career, serving as a key figure in the academic and research community. She is affiliated with Yale University, where she continues to contribute to groundbreaking research in neuroscience and cancer treatment.
Collaborations
Throughout her career, Susan has collaborated with esteemed colleagues, including Russell T Matthews and Diane M Jaworski. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Susan Hockfield's contributions to neuroscience and cancer treatment exemplify her dedication to improving patient outcomes. Her innovative patents and collaborative efforts continue to pave the way for advancements in medical science.